We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$2.55B
AUM Growth
+$71.7M
Cap. Flow
-$81.9M
Cap. Flow %
-3.21%
Top 10 Hldgs %
5.31%
Holding
1,322
New
211
Increased
334
Reduced
433
Closed
270

Top Buys

Rank Stock Value
1
MATX icon
Matsons
MATX
+$7.54M
2
PK icon
Park Hotels & Resorts
PK
+$6.53M
3
LNTH icon
Lantheus
LNTH
+$6.24M
4
PEGA icon
Pegasystems
PEGA
+$5.99M
5
CNM icon
Core & Main
CNM
+$5.29M

Sector Composition

Rank Sector Weight
1 Industrials 17.54%
2 Technology 15.26%
3 Financials 14.16%
4 Healthcare 13.52%
5 Consumer Discretionary 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDRX icon
576
GoodRx Holdings
GDRX
$972M
$1.17M 0.05%
164,795
-20,351
-11% -$135K
LEU icon
577
Centrus Energy
LEU
$3.36B
$1.17M 0.05%
28,130
+15,920
+130% +$730K
RNG icon
578
RingCentral
RNG
$3.24B
$1.16M 0.05%
33,240
-4,700
-12% -$158K
FIGS icon
579
FIGS
FIGS
$1.54B
$1.15M 0.05%
231,750
-29,480
-11% -$170K
RARE icon
580
Ultragenyx Pharmaceutical
RARE
$2.66B
$1.15M 0.04%
24,570
BWIN
581
Baldwin Insurance Group
BWIN
$2.52B
$1.14M 0.04%
39,534
-24,660
-38% -$648K
IVT icon
582
InvenTrust Properties
IVT
$2.79B
$1.13M 0.04%
44,084
UTI icon
583
Universal Technical Institute
UTI
$2.13B
$1.13M 0.04%
70,910
+59,350
+513% +$862K
KYMR icon
584
Kymera Therapeutics
KYMR
$9.08B
$1.13M 0.04%
28,084
-71,288
-72% -$2.55M
PRVA icon
585
Privia Health
PRVA
$3.15B
$1.13M 0.04%
57,571
+32,190
+127% +$680K
GDOT icon
586
Green Dot
GDOT
$743M
$1.13M 0.04%
+120,750
New +$1.06M
BKH icon
587
Black Hills Corp
BKH
$5.72B
$1.12M 0.04%
20,588
VCYT icon
588
Veracyte
VCYT
$4.62B
$1.12M 0.04%
50,702
-48,383
-49% -$1.18M
CUBE icon
589
CubeSmart
CUBE
$9.29B
$1.1M 0.04%
24,330
RCUS icon
590
Arcus Biosciences
RCUS
$3.74B
$1.1M 0.04%
58,258
-22,790
-28% -$394K
CPE
591
DELISTED
Callon Petroleum Company
CPE
$1.1M 0.04%
+30,640
New +$1M
EQC
592
DELISTED
Equity Commonwealth
EQC
$1.09M 0.04%
+57,950
New +$1.1M
XPER icon
593
Xperi
XPER
$358M
$1.08M 0.04%
89,180
-56,717
-39% -$624K
CCRN
594
DELISTED
Cross Country Healthcare
CCRN
$1.07M 0.04%
57,423
+29,463
+105% +$589K
FL
595
DELISTED
Foot Locker
FL
$1.07M 0.04%
37,730
+19,160
+103% +$551K
GPRO icon
596
GoPro
GPRO
$119M
$1.07M 0.04%
477,931
-216,310
-31% -$578K
NSSC icon
597
Napco Security Technologies
NSSC
$1.27B
$1.07M 0.04%
26,535
-106,944
-80% -$4.2M
SWTX
598
DELISTED
SpringWorks Therapeutics
SWTX
$1.06M 0.04%
21,500
-12,480
-37% -$577K
CRGY icon
599
Crescent Energy
CRGY
$3.76B
$1.06M 0.04%
88,810
+25,390
+40% +$286K
ZETA icon
600
Zeta Global
ZETA
$4.83B
$1.05M 0.04%
+96,430
New +$962K

Similar funds

Algert Global's Q1 2024 Portfolio in Review

As of Q1 2024, Algert Global held 1,322 positions worth $2.55B, up 2.9% from $2.48B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Algert Global withdrew a net $81.9M in Q1 2024, closing 270 positions and reducing 433 holdings. Its most notable exit was Armstrong World Industries, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Algert Global opened a new position in Jones Lang LaSalle worth $5.67M.

  • Algert Global's largest Q1 2024 buy was Jones Lang LaSalle: 29,060 shares worth $5.67M.
  • Algert Global added most to Matsons in Q1 2024, an estimated $7.54M increase.
  • Algert Global's biggest Q1 2024 reduction was Rush Enterprises Class A, cutting an estimated $8.38M.
  • Algert Global fully exited Armstrong World Industries in Q1 2024, selling an estimated $12.9M.
  • Algert Global's ten largest holdings make up 5.3% of its $2.55B portfolio in Q1 2024.
  • Algert Global opened 211 new positions and closed 270 in Q1 2024.
  • Algert Global's portfolio value rose 2.9% quarter-over-quarter to $2.55B.

Based on Algert Global's 13F filing for Q1 2024, filed 15 May 2024.